Suchergebnisse - "Cantini, Fabrizio"

PubPharm (12)

1

ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis) : Retrospective Study of Efficacy and Safety in Common Clinical Practice

enthalten in: Journal of personalized medicine | 2023

von Benucci, M. | Bardelli, M. | Cazzato, M. | +11

2

Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis : 2021 updated ITABIO statements

enthalten in: Expert opinion on drug safety | 2022

von Cantini, F. | Goletti, D. | Benucci, M. | +3

3

Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements

enthalten in: Expert opinion on drug safety | 2022

von Cantini, F. | Goletti, D. | Benucci, M. | +3

4

Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4 : possible fallout on non-medical switching

enthalten in: Annals of the rheumatic diseases | 2020

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2019 Feb;78(2):192-200. - PMID 30396903

5

Additional comment to : 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Scherlinger and Schaeverbeke

enthalten in: Annals of the rheumatic diseases | 2019

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648

6

Switching from the bio-originators to biosimilar : is it premature to recommend this procedure?

enthalten in: Annals of the rheumatic diseases | 2019

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648

7

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

enthalten in: Expert review of anti-infective therapy | 2018

von Goletti, D. | Petrone, L. | Ippolito, G. | +3

8

Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Bonovas, S. | Minozzi, S. | Lytras, T. | +13

9

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Minozzi, S. | Bonovas, S. | Lytras, T. | +14

10

Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

enthalten in: Seminars in arthritis and rheumatism | 2016

von Cantini, F. | Niccoli, L. | Nannini, C. | +21